My clinical specialty is Laboratory Hematology and Coagulation with a particular interest in evaluating bleeding and thrombotic problems, especially those arising from platelet function defects.
My research is focused on biomarkers that are predictive of arterial and venous thrombosis, and the interface between cancer and the complement and coagulation systems. My laboratory is currently studying a multifunctional cellular protein designated gC1qR/p33, which appears to be up-regulated in cancer and may play a role in tumor metastasis, inflammation, and thrombosis.
As Vice Chair of the Department of Laboratory Medicine, I am committed to improving patient care through innovative laboratory testing. I strive to support the clinical, research, and teaching missions of Memorial Sloan Kettering Cancer Center by building and coordinating multidisciplinary research teams of scientists, clinicians, and industry to integrate advances in science with clinical laboratory diagnosis, defining state-of-the-art, cost-effective diagnostic laboratory utilization, and training the next generation of leaders in laboratory medicine at the technical and professional levels.
- Clinical Expertise: Laboratory Hematology and Coagulation
- Languages Spoken: English
- Education: PhD, Basic Medical Sciences, Pathology, New York University
- Board Certifications: New York State Department of Health Certificate of Qualification in Hematology, Diagnostic Immunology, Cellular Immunology, Genetic Testing (limited to hemostatic factors)
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more